Up-regulation of sphingosine-1-phosphate receptors and sphingosine kinase 1 in the peri-ischemic area after transient middle cerebral artery occlusion in mice.
Animals
Brain Ischemia
/ metabolism
Disease Models, Animal
Infarction, Middle Cerebral Artery
/ metabolism
Lysophospholipids
/ metabolism
Male
Mice
Mice, Inbred C57BL
Neurons
/ metabolism
Phosphotransferases (Alcohol Group Acceptor)
/ metabolism
Receptors, Lysosphingolipid
/ metabolism
Signal Transduction
Sphingosine
/ analogs & derivatives
Sphingosine-1-Phosphate Receptors
/ metabolism
Transcriptional Activation
Cerebral ischemia
Sphingosine kinase
Sphingosine-1-phosphate
Sphingosine-1-phosphate receptor
Journal
Brain research
ISSN: 1872-6240
Titre abrégé: Brain Res
Pays: Netherlands
ID NLM: 0045503
Informations de publication
Date de publication:
15 07 2020
15 07 2020
Historique:
received:
30
11
2019
revised:
30
03
2020
accepted:
08
04
2020
pubmed:
13
4
2020
medline:
8
9
2021
entrez:
13
4
2020
Statut:
ppublish
Résumé
There is thought to be a strong relationship between sphingosine-1-phosphate (S1P) signaling and pathophysiolosy of cerebral ischemia. We examined the change of expression and distribution of S1P receptors (S1PRs) and sphingosine kinases (SphKs) after cerebral ischemia in male C57BL6/J mice using immunohistochemical analysis at 1, 5, 14, and 28 days after 30 min of transient middle cerebral artery occlusion (tMCAO). S1PR1, 3, and 5 were transiently induced in the cells, which were morphologically similar to neurons in the peri-infarct lesion with a peak seen at 1 day after tMCAO (p < 0.01 vs. sham control). S1PR2 appeared in the inner layer of vessels in the ischemic core (p < 0.01 vs. sham control) and the peri-infarct lesion (p < 0.01 vs. sham control) at the acute phase after tMCAO. However, SphK1 was strongly induced at 1 and 5 days after tMCAO (p < 0.01 vs. sham control) in the peri-infarct lesion, whereas SphK2 expression did not change. Western blot analysis at 1 and 5 days after 30 min of tMCAO revealed that the expression of S1PRs were transiently enhanced at the acute phase, which was consistent with the immunohistochemical results. Double immunofluorescent analysis revealed S1PR2/NG2- and S1PR2/CD31-, S1PR3/CD31-, and S1PR5/CD31-double positive cells in the peri-infarct lesion 1 day after tMCAO. The present results suggest that S1PRs and SphK1 may be important therapeutic targets for rescuing the peri-infarct lesion.
Identifiants
pubmed: 32278723
pii: S0006-8993(20)30187-6
doi: 10.1016/j.brainres.2020.146831
pii:
doi:
Substances chimiques
Lysophospholipids
0
Receptors, Lysosphingolipid
0
S1pr1 protein, mouse
0
Sphingosine-1-Phosphate Receptors
0
sphingosine 1-phosphate
26993-30-6
Phosphotransferases (Alcohol Group Acceptor)
EC 2.7.1.-
Sphk1 protein, mouse
EC 2.7.1.-
sphingosine kinase
EC 2.7.1.-
Sphingosine
NGZ37HRE42
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
146831Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.